Value of Chest Ultrasonography in ILD Screening

The main aim of this study is to detect the value of transthoracic ultrasonography in the diagnosis and assessment of ILDs in correlation to chest X- ray, blood gases, pulmonary function test and echocardiography and to compare it with high resolution CT (HRCT) as a golden diagnostic investigation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Interstitial Lung Disease Lung Diseases Lung Diseases, Interstitial Respiratory Tract Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

About this study

Interstitial lung disease (ILD) refers to a group of disorders that are characterized by varying combinations of inflammation and fibrosis involving the space between the epithelial and endothelial basement membranes.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Adults (≥18 years) diagnosed with ILD
All patients must fulfil the 2018 criteria for HRCT chest finding for the diagnosis of Usual interstitial pneumonia (UIP) form

Exclusion criteria

Patients with cardiac diseases (Left-sided Heart failure, pulmonary edema) [they may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings].
Patients with chronic kidney diseases (as patients presented with nephrogenic pulmonary edema may have findings of multiple B lines on transthoracic ultrasound examination which mimic ILD findings).

Treatment and study plan

Primary outcomes

Sensitivity and specificity of the lung sonography for interstitial lung disease screening

Time frame: 12 months

To estimate the sensitivity and specificity of the lung sonography for interstitial disease screening in comparison with HRCT. [Time Frame: 12 months]

Sponsors and collaborators

Lead sponsor

Aswan University

Other

Registry information

Official study title

Role od Chest Ultrasonography in Interstitial Lung Diseases

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: Feb 15, 2024
Registry last updated: Feb 15, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed